durapatite has been researched along with rifampin in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 9 (81.82) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, KM; Figurski, D; Fine, DH; Furgang, D; Goncharoff, P; Schreiner, H | 1 |
| Ishimaru, D; Ito, Y; Ogawa, H; Shimizu, K | 1 |
| Devaraj, SN; Girija, EK; Kalkura, SN; Raja, SB; Savithri, K; Sridevi, TS; Thamizhavel, A; Vani, R | 1 |
| Dong, J; Du, Y; Liu, H; Liu, Y; Ma, J; Zhang, S | 1 |
| Cao, ZD; Jiang, DM; Li, YJ; Wang, X; Wang, ZL; Wu, J; Yan, L; Yi, YF | 1 |
| Jiang, D; Liu, Y | 1 |
| Jiang, D; Liu, Y; Zhu, J | 1 |
| Cui, X; Li, BN; Li, G; Li, L; Ma, YG; Shi, F; Wang, F; Wang, H; Wang, L; Weng, J; Zhang, C; Zhou, CX; Zhou, Z | 1 |
| Jiang, D; Liang, Q; She, S; Song, X; Wang, C; Wang, Z | 1 |
| Amarnath Praphakar, R; Rajan, M; Sam Ebenezer, R; Shakila, H; Sumathra, M; Vignesh, S | 1 |
| Kumar, A; Lidgren, L; Matheshwaran, S; Murugan, PA; Nair, NN; Qayoom, I; Raina, DB; Tägil, M; Teotia, AK; Verma, R | 1 |
1 review(s) available for durapatite and rifampin
| Article | Year |
|---|---|
Surgical treatment of an infant with Bacille Calmette-Guérin osteomyelitis extending across the growth plate.
Topics: Anti-Bacterial Agents; BCG Vaccine; Bone Substitutes; Curettage; Durapatite; Growth Plate; Humans; Infant; Isoniazid; Knee Joint; Male; Meta-Analysis as Topic; Osteomyelitis; Pyrazinamide; Recurrence; Reoperation; Rifampin; Tibia | 2011 |
10 other study(ies) available for durapatite and rifampin
| Article | Year |
|---|---|
Colonization and persistence of rough and smooth colony variants of Actinobacillus actinomycetemcomitans in the mouths of rats.
Topics: Actinobacillus Infections; Aggregatibacter actinomycetemcomitans; Alveolar Bone Loss; Analysis of Variance; Animals; Antibiotics, Antitubercular; Antibodies, Bacterial; Bacterial Adhesion; Cells, Cultured; Colony Count, Microbial; Drug Resistance, Bacterial; Durapatite; Ecology; Epithelial Cells; Food Microbiology; Germ-Free Life; Humans; Linear Models; Male; Mouth; Mouth Mucosa; Phenotype; Rats; Rats, Sprague-Dawley; Rifampin; Saliva; Statistics, Nonparametric; Stomach | 2001 |
Surfactant free rapid synthesis of hydroxyapatite nanorods by a microwave irradiation method for the treatment of bone infection.
Topics: Alkaline Phosphatase; Anti-Bacterial Agents; Bacterial Adhesion; Bone and Bones; Bone Diseases; Cell Line, Tumor; Cell Proliferation; Cell Survival; Ciprofloxacin; Durapatite; Escherichia coli; Humans; Microbial Sensitivity Tests; Microwaves; Nanotechnology; Nanotubes; Rifampin; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Staphylococcus aureus; Staphylococcus epidermidis; Surface Properties; Surface-Active Agents; X-Ray Diffraction | 2011 |
Preparation, characterization, and in vitro cytotoxicity evaluation of a novel anti-tuberculosis reconstruction implant.
Topics: Animals; Antitubercular Agents; Cell Line; Cell Survival; Drug Compounding; Drug Implants; Durapatite; Mice; Microscopy, Electron, Scanning; Nanocomposites; Osteoblasts; Polyesters; Porosity; Rifampin; Spectroscopy, Fourier Transform Infrared; Tuberculosis, Osteoarticular; X-Ray Diffraction | 2014 |
Treatment of Staphylococcus aureus-induced chronic osteomyelitis with bone-like hydroxyapatite/poly amino acid loaded with rifapentine microspheres.
Topics: Amino Acids; Animals; Anti-Bacterial Agents; Chronic Disease; Delayed-Action Preparations; Drug Carriers; Durapatite; Lactic Acid; Microspheres; Osteomyelitis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Rifampin; Staphylococcal Infections; Staphylococcus aureus | 2015 |
Effect of bone-like hydroxyapatite/poly amino acid loaded with rifapentine microspheres on bone and joint tuberculosis in vitro.
Topics: Cell Differentiation; Cell Line, Tumor; Drug Carriers; Durapatite; Humans; Lactic Acid; Microbial Sensitivity Tests; Microspheres; Mycobacterium tuberculosis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rifampin; Tuberculosis, Osteoarticular; Wnt Signaling Pathway | 2017 |
Release characteristics of bone‑like hydroxyapatite/poly amino acid loaded with rifapentine microspheres in vivo.
Topics: Alanine Transaminase; Amino Acids; Animals; Aspartate Aminotransferases; Blood Urea Nitrogen; Bone and Bones; Creatinine; Disease Models, Animal; Durapatite; Male; Microspheres; Organ Specificity; Rabbits; Rifampin | 2017 |
A bioactive implant in situ and long-term releases combined drugs for treatment of osteoarticular tuberculosis.
Topics: Animals; Antitubercular Agents; Biocompatible Materials; Bone Regeneration; Cell Adhesion; Cell Line; Cell Survival; Delayed-Action Preparations; Drug Delivery Systems; Drug Liberation; Drug Therapy, Combination; Durapatite; Humans; Isoniazid; Mice; Mycobacterium tuberculosis; Polyvinyl Alcohol; Prostheses and Implants; Rabbits; Rifampin; Tissue Scaffolds; Tuberculosis, Osteoarticular | 2018 |
Development of dual delivery antituberculotic system containing rifapentine microspheres and adipose stem cells seeded in hydroxyapatite/tricalcium phosphate.
Topics: Adipocytes; Animals; Antitubercular Agents; Calcium Phosphates; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Drug Delivery Systems; Durapatite; Female; Microspheres; Particle Size; Rabbits; Rifampin; Structure-Activity Relationship; Surface Properties | 2019 |
Fabrication of bioactive rifampicin loaded κ-Car-MA-INH/Nano hydroxyapatite composite for tuberculosis osteomyelitis infected tissue regeneration.
Topics: Animals; Antitubercular Agents; Carrageenan; Cell Line; Drug Delivery Systems; Drug Liberation; Durapatite; Erythrocytes; Hemolysis; Humans; Isoniazid; Klebsiella pneumoniae; Macrophages; Maleic Anhydrides; Mice; Nanocomposites; Osteoblasts; Osteomyelitis; Regeneration; Rifampin; Staphylococcus aureus; Tuberculosis | 2019 |
A biphasic nanohydroxyapatite/calcium sulphate carrier containing Rifampicin and Isoniazid for local delivery gives sustained and effective antibiotic release and prevents biofilm formation.
Topics: Antitubercular Agents; Biofilms; Bone Regeneration; Calcium Sulfate; Computational Biology; Delayed-Action Preparations; Drug Carriers; Drug Interactions; Drug Therapy, Combination; Durapatite; Isoniazid; Microbial Sensitivity Tests; Mycobacterium smegmatis; Rifampin; Tuberculosis, Osteoarticular | 2020 |